Drug companies should be held more accountable for their human rights responsibilities.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 20927358.
- Also identified by DOI 10.1371/journal.pmed.1000344 and PMC identifier 2946955.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The <i>PLoS Medicine</i> Editors argue that drug companies should be held more accountable for their human rights responsibilities.
Medical subject headings
- Drug Industry
- Human Rights